Over the past 20 years, drug development has led to numerous medications with the potential to treat intraocular disease. These medications usually require systemic or frequent topical administration, which can limit the types of medications that can be used and the diseases that can be treated eVectively.
No takes yet. Share an insight, caveat, or question.
Velez et al. (1999) studied this question.